Hassan, M., N. Merza, Y. Nawras, H. Alfatlawi, hasan al obaidi, O. Saab, K. Al Zubaidi, D. Al-sabbagh, S. mansur, M. Algodi, O. Al Najafi, R. Matbachi, T. Al Hamdany, Z. Noori, and A. Kobeissy. “Effect of Pemafibrate, a Selective Peroxisome Proliferator-Activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis”. Translation: The University of Toledo Journal of Medical Sciences, vol. 13, no. S3, June 2025, doi:10.46570/utjms-2025-1397.